Regression of Metastatic Non-Small Cell Lung Cancer with Low Molecular Weight Heparin

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Thromb Haemost 2002; 88(04): 686
DOI: 10.1055/s-0037-1613276

Letters to the Editor

Schattauer GmbH

Authors

James T. Loynes

²Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, Vermont, USA
Leo R. Zacharski

¹Department of Veterans Affairs Medical Center, White River Jct., Vermont, USA
James R. Rigas

²Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, Vermont, USA

Received 20. Mai 2002

Accepted 22. Mai 2002

Publikationsdatum:
09. Dezember 2017 (online)

References
1 Zacharski LR, Ornstein DL. Heparin and cancer. Thromb Haemost 1998; 80: 10-23.

Reference Link Ris
Thieme Connect PubMed Suche in Google Scholar
2 Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000; 342 (26) 1953-8.

Reference Link Ris
Crossref PubMed Suche in Google Scholar
3 Zacharski LR, Ornstein DL, Mamourian AC. Low-molecular-weight heparin and cancer. Semin Thromb Hemost 2000; 26 (Suppl. 01) 69-77.

Reference Link Ris
Thieme Connect PubMed Suche in Google Scholar